Ford’s EV Strategy Shift: Impact on Tesla, Rivian, Lucidby Mark Eisenberg 26.08.2024Ford's EV strategy changes benefit Tesla, Rivian, Lucid by reducing competition and opening market opportunities.
Cava’s Q2 Earnings Preview Amid Stock Surgeby Mark Eisenberg 22.08.2024Cava's stock hits record as Q2 results loom. Sales expected to rise, driven by new menu items.
Stifel Downgrades Medtronic: Growth Delays Impact Outlookby Mark Eisenberg 22.08.2024Stifel downgrades Medtronic to 'Hold' due to slow growth in key initiatives like HUGO system, affecting market competitiveness.
Stifel Lowers Celsius Holdings Target to $61, Maintains Buy Ratingby Mark Eisenberg 07.08.2024Stifel revises Celsius Holdings' price target to $61, citing future sales adjustments and increased spending. Buy rating maintained.
ResMed, Inspire Medical Drop After Lilly’s Zepbound Studyby Mark Eisenberg 24.06.2024"ResMed and Inspire Medical stocks plummet after Eli Lilly's Zepbound trial success; Citi downgrades RMD, sees market shift. Read more ...
Bitcoin Collapse and S&P 500: A Looming Stock Decline?by John Darbie 24.06.2024"Crypto analysts link Bitcoin's drop to a potential S&P 500 decline, citing historical correlations and Federal Reserve policies. Discover market ...
Align Technology Sees Diverse Investor Interest and Mixed Ratingsby Lilu Anderson 22.06.2024AIG sells 4,921 shares of Align Technology, reducing holdings by 19%. Major investors and analysts shift positions and ratings. Stock ...
HighPoint Buys 1,271 Shares in Align Technology, Others Followby Lilu Anderson 21.06.2024"HighPoint Advisor Group invests in Align Tech, joining other major investors. Analysts offer a moderate buy rating with potential future ...
Nvidia’s Stock Target Raised by Stifel Amid Growth Prospectsby Mark Eisenberg 19.06.2024Nvidia’s growth in high-performance computing and AI drives Stifel to raise price target to $165. Risk factors include trade restrictions ...
Boston Scientific Acquires Silk Road Medical; Shares Jump 24%by Mark Eisenberg 18.06.2024Boston Scientific to acquire Silk Road Medical for $1.16B, boosting Silk Road shares by 24%. Expected to finalize by H2 ...